Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to 0.61.

  • Korro Bio's Equity Ratio fell 1688.86% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61, marking a year-over-year decrease of 1688.86%. This contributed to the annual value of 0.71 for FY2024, which is 749.88% down from last year.
  • As of Q3 2025, Korro Bio's Equity Ratio stood at 0.61, which was down 1688.86% from 0.64 recorded in Q2 2025.
  • Korro Bio's 5-year Equity Ratio high stood at 0.79 for Q2 2024, and its period low was 1.34 during Q4 2022.
  • In the last 5 years, Korro Bio's Equity Ratio had a median value of 0.71 in 2021 and averaged 0.58.
  • As far as peak fluctuations go, Korro Bio's Equity Ratio plummeted by 29027.43% in 2022, and later soared by 15707.84% in 2023.
  • Quarter analysis of 5 years shows Korro Bio's Equity Ratio stood at 0.71 in 2021, then plummeted by 290.27% to 1.34 in 2022, then skyrocketed by 157.08% to 0.77 in 2023, then dropped by 7.5% to 0.71 in 2024, then decreased by 13.54% to 0.61 in 2025.
  • Its Equity Ratio stands at 0.61 for Q3 2025, versus 0.64 for Q2 2025 and 0.69 for Q1 2025.